Vitrolife Group
Manufacturing · Sweden · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
Goeteborg, Vaestra Goetaland, SwedenPhone Number
+46 84025874Website
www.vitrolifegroup.comRevenue
$380.6 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Vitrolife Group
Vitrolife Group is a global provider of medical devices and genetic testing solutions focused on reproductive health. They offer a premium quality portfolio of products and services that support the entire IVF journey, including innovative technologies and genetic testing. Their primary clients are IVF clinics and reproductive health professionals aiming to achieve successful treatment outcomes. With a commitment to sustainability and innovation, Vitrolife Group strives to help individuals fulfill their dream of having a healthy baby.Explore more
Vitrolife Group Org Chart
ES
Vice President, Area of Sales
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Vitrolife Group your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Vitrolife Group launches new products
Check if Vitrolife Group has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Vitrolife Group has new funding data
Congratulate Masked Content for being promoted to Masked Content at Vitrolife Group
Click to see if Vitrolife Group had a recent Job posting/layoffs
Earning: See what the market has to say on Vitrolife Group recently announced quarterly report
Vitrolife Group, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Vitrolife Group is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined Vitrolife Group as Masked Content
Find 3 more new buyers
Compare Similar Companies to Vitrolife Group
Compare insights from companies similar to Vitrolife Group, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Vitrolife Group
$380.6M
1K - 5K
Private
-
1994
ES
Erin SchardtSenior VP & General Manager (North America)
Company Profile Activity
Activity Insights
Vitrolife Group is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Vitrolife Group is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Vitrolife Group.
Vitrolife Group Tech Stack
A closer look at the technologies used by Vitrolife Group
See more technologies
Most Recent Scoops
Pain Point
Vitrolife Group is experiencing significant operational disruptions in the Middle East within its EMEA region, where the ongoing regional conflict has caused IVF cycle activity to decline substantially, with distributors halting restocking and airspace closures intermittently preventing goods from being shipped into the region.
Pain Point, Logistics / Supply Chain
Pain Point
Vitrolife Group is experiencing a year-over-year decline in IVF cycle activity in China within its APAC region, a trend the company expects to continue based on population demographic factors.
Pain Point
Earnings
Vitrolife Group has reported that the AGM held on May 5, 2026 approved a dividend of SEK 1.10 per share, totaling 149 million SEK, for full year 2025.
Earnings, Finance, Financial Transactions
Earnings
Vitrolife Group has reported that operational expenses were reduced by 48 million SEK compared to Q2 last year, reflecting the positive impact of the ongoing restructuring program and continued cost discipline, including a one-time positive effect of 13 million SEK primarily from a VAT accrual release and a positive currency revaluation effect of 8 million SEK.
Spending/Investment, Accounting, Financial Reporting, Finance, Financial Operations, Tax
Earnings
Share Placement, Finance
Vitrolife Group News & Media
CEO Bronwyn Brophy O'Connor has decided to leave Vitrolife Group
GOTHENBURG, Sweden, May 22, 2026 /PRNewswire/ -- Vitrolife AB (publ) today announces that CEO Bronwyn Brophy O'Connor has decided to leave the company to assume a CEO role in a different area of the medtech industry. Vitrolife Group's Board has received Bronwyn's resignation and will...Vitrolife Group has today published its Annual and Sustainability Report for 2025
GOTHENBURG, Sweden, March 26, 2026 /PRNewswire/ -- The Annual and Sustainability Report is now available digitally in English and Swedish at www.vitrolifegroup.com. The Annual Report in accordance with European Single Electronic Format (ESEF) is available in Swedish. Vitrolife Group has...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Vitrolife Group
Sign Up For FreeTo access detailed company insights
Vitrolife Group is a global provider of medical devices and genetic testing solutions focused on reproductive health. They offer a premium quality portfolio of products and services that support the entire IVF journey, including innovative technologies and genetic testing. Their primary clients are IVF clinics and reproductive health professionals... Read More
